References :
1. Morimoto A, Oh Y, Shioda Y, et al. Recent advances in Langerhans cell histiocytosis. Pediatr Int. 2014 ;56:451-61.
2. Girschikofsky M, Arico M, Castillo D, et al. Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis.2013; 8:72.
3. Allen CE, Merad M, McClain KL. Langerhans-Cell Histiocytosis. N Engl J Med. 2018 ;379:856-868.
4. Yi X, Han T, Zai H, Long X, et al. Liver involvement of Langerhans’ cell histiocytosis in children. Int J Clin Exp Med. 2015 ;8 :7098-106.
5. Squires RH Jr, Weinberg AG, Zwiener RJ, et al. Langerhans’ cell histiocytosis presenting with hepatic dysfunction. J Pediatr Gastroenterol Nutr. 1993;16:190-3.
6. Minkov M. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions. Paediatr Drugs. 2011;13:75-86.
7. A multicentre retrospective survey of Langerhans’ cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans’ Cell Histiocytosis Study Group. Arch Dis Child. 1996; 75:17-24.
8.Rigaud C, Barkaoui MA, Thomas C, et al.Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age. Br J Haematol. 2016 Sep;174:887-98.
9.Ziogas, IA, Kakos CD, Wu WK et al. Liver Transplantation for Langerhans Cell Histiocytosis: A US Population-Based Analysis and Systematic Review of the Literature. Liver Transpl.2021.27: 1181-1190.
10. Haupt R, Minkov M, Astigarraga I, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60:175-184.
11. Langerhans’ cell histiocytosis of the liver. Differential diagnosis of a rare chronic destructive sclerosing cholangitis. Pathologe. 2003 ;24:119-23.
12. Kaplan KJ, Goodman ZD, Ishak KG. Liver involvement in Langerhans’ cell histiocytosis: a study of nine cases. Mod Pathol. 1999 ;12:370-8.
13. Jessop S, Crudgington D, London K, et al. FDG PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Blood Cancer. 2020 ;67:e28034.
14. Sarin SK, Choudhury A, Sharma MK et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int.2019; 13.353–390 .
15. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460.
16. Allen CE, McClain KL. Treatment of Langerhans cell histiocytosis: it is time to learn from the past: response to Minkov and Rodriguez-Galindo. Br J Haematol. 2015;171:150-151.
17. Simko SJ, McClain KL, Allen CE. Up-front therapy for LCH: is it time to test an alternative to vinblastine/prednisone?. Br J Haematol. 2015;169:299-301.
18. Braier J, Ciocca M, Latella A, et al. Cholestasis, sclerosing cholangitis, and liver transplantation in Langerhans cell Histiocytosis. Med Pediatr Oncol. 2002;38:178-82.
19.  Newell KA, Alonso EM, Kelly SM, et al. Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children. J Pediatr. 1997 ;131:98-104.
20. Hadzic N, Pritchard J, Webb D, et al. Recurrence of Langerhans cell histiocytosis in the graft after pediatric liver transplantation. Transplantation. 2000;70:815-9.
21. Floyd J, Mirza I, Sachs B, Perry MC. Hepatotoxicity of chemotherapy. Semin Oncol. 2006 ;33:50-67.
22. Tang Y, Zhang Z, Chen M, et al. Severe sclerosing cholangitis after Langerhans cell histiocytosis treated by liver transplantation: An adult case report. Medicine (Baltimore). 2017;96:e5994.
23. Bahirwani R, Reddy KR. Drug-induced liver injury due to cancer chemotherapeutic agents. Semin Liver Dis. 2014;34:162-71.
24. Morimoto A, Ikushima S, Kinugawa N, et al. Japan Langerhans Cell Histiocytosis Study Group. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study. Cancer. 2006;107:613-9.
25. Chen C, Gu G, Zhou T, et al. Combination of Neoadjuvant Therapy and Liver Transplantation in Pediatric Multisystem Langerhans Cell Histiocytosis With Liver Involvement. Front Oncol. 2020. 7;10:566987.
26. Wang, Q., Jin, S., Xiang, B. et al.  Liver transplantation in a child with liver cirrhosis caused by Langerhans cell histiocytosis: a case report. BMC Pediatr.2022;22:18.